ASC-44-F

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameASC-44-F
Drug Alias NameASC-44-F
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNerve growth factor receptors antagonistsFatty acid synthase inhibitors
TargetsFatty acid synthaseBile acid receptor FXR
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAscletis Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAscletis Pharma Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A